These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 26690937

  • 1. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
    Sandow N, Diesing D, Sarrafzadeh A, Vajkoczy P, Wolf S.
    Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
    [Abstract] [Full Text] [Related]

  • 2. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [Abstract] [Full Text] [Related]

  • 3. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
    Hajizadeh Barfejani A, Rabinstein AA, Wijdicks EFM, Clark SL.
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
    [Abstract] [Full Text] [Related]

  • 4. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Cho WS, Kang HS, Kim JE, Kwon OK, Oh CW, Son YJ, Know BJ, Jung C, Hang MH.
    Interv Neuroradiol; 2011 Jun; 17(2):169-78. PubMed ID: 21696654
    [Abstract] [Full Text] [Related]

  • 5. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D, Etminan N, Mayer SA, Aldrich EF, Diringer MN, Schmutzhard E, Faleck HJ, Ng D, Saville BR, Macdonald RL, NEWTON Investigators.
    Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
    [Abstract] [Full Text] [Related]

  • 6. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
    Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, Diringer MN, Hoh BL, Mocco J, Strange P, Faleck HJ, Miller M.
    Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
    [Abstract] [Full Text] [Related]

  • 7. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    van den Bergh WM, Mees SM, Rinkel GJ.
    Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
    [No Abstract] [Full Text] [Related]

  • 8. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
    Vázquez-Medina A, Turnbull MT, James CL, Cowart JB, Lesser E, Carter RE, Ross OA, Miller DA, Meschia JF, De Jesús Espinosa A, Weinshilboum R, Freeman WD.
    Pharmacogenomics J; 2024 Jun 18; 24(4):19. PubMed ID: 38890281
    [Abstract] [Full Text] [Related]

  • 9. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
    Kieninger M, Gruber M, Knott I, Dettmer K, Oefner PJ, Bele S, Wendl C, Tuemmler S, Graf B, Eissnert C.
    Neurocrit Care; 2019 Aug 18; 31(1):32-39. PubMed ID: 30725331
    [Abstract] [Full Text] [Related]

  • 10. Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients.
    Cho S, Bales J, Tran TK, Korab G, Khandelwal N, Joffe AM.
    Ann Pharmacother; 2016 Sep 18; 50(9):718-24. PubMed ID: 27273676
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Ditz C, Matone MV, Schwachenwald B, Küchler J.
    Neurosurg Rev; 2024 Jan 09; 47(1):37. PubMed ID: 38191859
    [Abstract] [Full Text] [Related]

  • 13. Nimodipine: test your drug IQ.
    Devlin MM.
    Nursing; 2008 Jul 09; 38(7):56cc1-2. PubMed ID: 18580671
    [Abstract] [Full Text] [Related]

  • 14. In brief: nimodipine oral solution (Nymalize).
    Med Lett Drugs Ther; 2013 Aug 19; 55(1423):68. PubMed ID: 23959389
    [No Abstract] [Full Text] [Related]

  • 15. Does Nimodipine Interruption due to High Catecholamine Doses Lead to a Greater Incidence of Delayed Cerebral Ischemia in the Setting of Aneurysmal Subarachnoid Hemorrhage?
    Hernández-Durán S, Mielke D, Rohde V, Malinova V.
    World Neurosurg; 2019 Dec 19; 132():e834-e840. PubMed ID: 31404696
    [Abstract] [Full Text] [Related]

  • 16. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D, Beseoglu K, Turowski B, Steiger HJ.
    Clin Neurol Neurosurg; 2008 Sep 19; 110(8):784-90. PubMed ID: 18554777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage.
    Stiefel MF, Heuer GG, Abrahams JM, Bloom S, Smith MJ, Maloney-Wilensky E, Grady MS, LeRoux PD.
    J Neurosurg; 2004 Oct 19; 101(4):594-9. PubMed ID: 15481712
    [Abstract] [Full Text] [Related]

  • 19. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan 19; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 20. Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
    Goel R, Aggarwal A, Salunke P, Kumar A, Chhabra R.
    Br J Neurosurg; 2016 Aug 19; 30(4):407-10. PubMed ID: 26999260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.